ULTRAGENYX PHARMACEUTICAL INC. Finance Lease, Weighted Average Discount Rate, Percent
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Finance Lease, Weighted Average Discount Rate, Percent of 5.10% as of 2022-12-31, per its 10-K filed 2024-02-21.
Discontinued › Notes › Leases
us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent · last filed 2024-02-21
- 2022-12-31: Finance Lease, Weighted Average Discount Rate, Percent 5.10%; Finance Lease, Weighted Average Discount Rate, Percent as first filed 5.13%.
- 2021-12-31: Finance Lease, Weighted Average Discount Rate, Percent 5.44%.
- 2020-12-31: Finance Lease, Weighted Average Discount Rate, Percent 5.58%.
| Period end | Finance Lease, Weighted Average Discount Rate, Percent | Finance Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2022-12-31 | 5.10% 10-K · filed 2024-02-21 | 5.13% 10-K · filed 2023-02-17 |
| 2021-12-31 | 5.44% 10-K · filed 2023-02-17 | |
| 2020-12-31 | 5.58% 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |